Impact of long‐term administration of maralixibat on children with cholestasis secondary to Alagille syndrome

There is growing interest in, but limited data about, intestinal bile acid transport inhibitors as treatment for cholestatic liver disease. The current analyses combine two similar randomized placebo‐controlled trials with subsequent extension phases investigating the impact of maralixibat in childr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shneider, Benjamin L., Spino, Catherine A., Kamath, Binita M., Magee, John C., Ignacio, Rosalinda V., Huang, Suiyuan, Horslen, Simon P., Molleston, Jean P., Miethke, Alexander G., Kohli, Rohit, Leung, Daniel H., Jensen, M. Kyle, Loomes, Kathleen M., Karpen, Saul J., Mack, Cara, Rosenthal, Philip, Squires, Robert H., Baker, Alastair, Rajwal, Sanjay, Kelly, Deirdre, Sokol, Ronald J., Thompson, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315125/
https://www.ncbi.nlm.nih.gov/pubmed/35672955
http://dx.doi.org/10.1002/hep4.1992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315125/
https://www.ncbi.nlm.nih.gov/pubmed/35672955
http://dx.doi.org/10.1002/hep4.1992

Ejemplares similares